跳至主要内容
临床试验/NCT05700981
NCT05700981Enrolling By Invitation不适用

Colon Capsule Endoscopy in Patients With Colonic Diverticulitis: a Randomized Controlled Trial

Odense University Hospital1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2023年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
120
试验地点
1
主要终点
Patient discomfort and preference

研究概览

简要总结

Introduction: Follow-up after colonic diverticulitis is a common indication for colonoscopy, even though studies have shown a low risk of positive findings in this population. The objective is to investigate colon capsule endoscopy (CCE) as a follow-up examination in patients with colonic diverticulitis compared to colonoscopy, on patient satisfaction and clinical performance.

Methods and Analysis: The investigators will conduct a single centre prospective randomized controlled trial. Patients seen at Odense University Hospital with acute diverticulitis confirmed by CT will be included and randomized to either follow-up by colonoscopy or CCE. Detection of suspected cancer, more than two polyps or any number of polyps larger than 9mm in CCE will generate an invitation to a diagnostic colonoscopy for biopsies or polyp removal. The investigators will compare colonoscopy and CCE regarding patient satisfaction and tolerance, the number of complete examinations, the number of patients referred to a subsequent colonoscopy after CCE and the prevalence of diverticula, polyps, cancers and other abnormal findings.

详细描述

Colon diverticulosis (CD) is extremely common and the prevalence seems to increase globally. The prevalence of CD increases with age and two-thirds of the adult population eventually develop CD. In the US the prevalence of CD was 32.6 % in patients aged 50-59 years and 71.4% in patients > 80 years of age. CD is often detected incidentally during optical colonoscopy (OC) or by computer tomography (CT). In approximately 25 % of patients with CD symptomatic colon diverticular disease develop typically comprising bloating, abdominal pain and change in bowel habits. Progression to diverticulitis is estimated to appear in approximately 1%. Most patients present with uncomplicated diverticulitis and are managed by general practitioners (GP) with the use of painkillers and oral antibiotics. Complicated diverticulitis due to perforation can be classified according to Hinchey et al. as a guidance to surgeon as to how conservative they can be. Hinchey level 1-2 can be managed conservatively. In the case of Hinchey level 3 and 4 it requires a laparoscopy with peritoneal lavage or laparotomy with colon resection and stoma formation, respectively. In patients presenting at the GP with intractable pain or signs of sepsis admission to hospital services is mandatory. Upon hospitalization, CT is the preferred diagnostic imaging modality in patients presenting with abdominal pain and suspected diverticulitis. If colonic diverticulitis is described as the symptoms-eliciting pathology without complications comprising abscess or bowel perforation patients are typically discharged from hospital with painkillers and offered an OC within 4-6 weeks, when the inflammation has resolved, to confirm the diverticulitis diagnosis. Routine OC after an episode of diverticulitis is recommended by the majority of international guidelines including Danish guidelines on handling of patients with diverticulitis. Due to a very low risk of malignancy in patients with diverticulitis the relevance of routine OC has been questioned in a recent review. The research in Colon Capsule Endoscopy (CCE) has evolved substantially since the introduction in 2006. More studies have reported a diagnostic yield equal to OC also in regard to larger polyps > 9 mm. In contrast to OC, CCE does not offer the possibility of biopsy or removal polyp. Hence, the ideal population for CCE needs to have low risk of findings with the need of endoscopic intervention. CCE is without pain and the risk of complications is extremely low compared to colonoscopy for which the estimated risk of major bleeding or perforation is 12 per 10,000 patients.

The investigators aimed to evaluate the effect of introducing CCE on patient satisfaction and discomfort compared to colonoscopy as a follow-up examination in patients with diverticulitis and the impact of introducing CCE on the need for subsequent colonoscopy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients above the age of 18 with in-hospital CT-diagnosed diverticulitis

排除标准

  • •Recent imaging of the colonic mucosa and therefore no indication for renewed endoscopy, evaluated by the attending physician.
  • •Colonic CT findings that require biopsy (suspected cancer) or polyp removal.
  • •CT-verified stenosis in the gastrointestinal (GI) tract.
  • •Cardiac pacemaker
  • •Renal insufficiency
  • •Pregnancy/breastfeeding
  • •Allergies towards active substances administered in the trial
  • •Unable to provide oral and written informed consent

研究组 & 干预措施

Colon capsule endoscopy

Experimental

Patients randomized to colon capsule endoscopy

干预措施: colon capsule endoscopy (Diagnostic Test)

Colonoscopy

No Intervention

Patients randomized to colonoscopy

结局指标

主要结局

Patient discomfort and preference

时间窗: 6 months

These patient-reported outcomes as well as an evaluation on patient preferences will be investigated using questionnaires

次要结局

  • Re-investigation rate(6 months)
  • Number of neoplastic lesions(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

进行中(未招募)
1 期
Which bowel preparation regime gives the most optimal Colon Capsule Endocscopy in patients with high risk polyps.Endoscopic examination of the colon and rectum for polyps and cancersMedDRA version: 19.0Level: LLTClassification code 10010026Term: Colorectal cancer Duke's ASystem Organ Class: 100000004864MedDRA version: 19.0Level: LLTClassification code 10010027Term: Colorectal cancer Duke's CSystem Organ Class: 100000004864MedDRA version: 19.0Level: LLTClassification code 10010028Term: Colorectal cancer Duke's DSystem Organ Class: 100000004864MedDRA version: 19.0Level: LLTClassification code 10010029Term: Colorectal cancer NOSSystem Organ Class: 100000004864MedDRA version: 19.0Level: LLTClassification code 10010024Term: Colorectal cancer Duke's B1System Organ Class: 100000004864MedDRA version: 19.0Level: LLTClassification code 10010025Term: Colorectal cancer Duke's B2System Organ Class: 100000004864MedDRA version: 19.0Level: LLTClassification code 10052362Term: Metastatic colorectal cancerSystem Organ Class: 100000004864MedDRA version: 19.0Level: LLTClassification code 10010031Term: Colorectal cancer stage B2System Organ Class: 100000004864
EUCTR2016-002237-30-DKOdense University Hospital180
终止
不适用
Colon Capsule Endoscopy Versus Standard Colonoscopy in Ulcerative ColitisUlcerative Colitis
NCT00837304University Hospital Muenster14
已完成
不适用
Capsule Colonoscopy in Crohn's Disease and Its Correlation With Conventional Colonoscopy and Faecal CalprotectinCrohn's Disease
NCT02624414Melbourne Health47
招募中
不适用
Colon Capsule Endoscopy as an Alternative to CT-colonography in Colorectal Cancer ScreeningThis study focuses on colorectal cancer screening (including the diagnostic yield for polyps and colorectal cancer).
NL-OMON25818MLDS grant, Colon capsules and corresponding materials will be provided by Medtronic100
已完成
不适用
Evaluation of PillCam IBD Capsule Endoscopy System in Visualization of Lesions in the Colon Indicative of Ulcerative Colitis DiseaseUlcerative Colitis
NCT02025777Medtronic - MITG30
Colon Capsule Endoscopy in Patients With Colonic... | 临床试验